When High-Stakes ADC Decisions Can’t Wait for More Material or Better Data

Early ADC development often requires critical decisions to be made with limited data and scarce material. In this webinar, discover a streamlined analytical approach that enables accurate measurement of antibody-drug conjugate (ADC) concentration and drug-to-antibody ratio (DAR) without resource-intensive calibration assays.

Attendees will learn how combining LC-MRM with a single UV280 measurement can generate reliable concentration data, establish reusable linker-payload extinction coefficients, and accelerate candidate evaluation. The session will provide practical insights into improving developability assessments and making more confident ADC decisions earlier in the development process.